Degeneration of the macula in the eye occurs with age and results in blurred or distorted vision, often with a dark spot blocking the centre of the visual field. Unfortunately, the progression of the disease is unpredictable and clinical planning is often difficult, leading to irreversible progression of the disease.

Occutrack’s patented Crystalsight AI detects the user’s gaze points on the screen and generates a new pattern elsewhere on the screen. All the user has to do is look at the screen! Our system uses gaze tracking and advanced eye-tracking algorithms to provide a comprehensive and intelligent assessment of a person’s visual performance. By tracking these optokinetic movements with displayed patterns on the screen, eye health can be determined. Automated Vision Assessment and Impairment Detection through Gaze Analysis (“AVIGA”).

Our technology is fully developed in Singapore and is becoming increasingly important as it provides clinicians with the ability to predict and accurately administer injections for disease recurrence, track treatment efficacy with reliable quantitative results.

VISIT WEBSITE